2025 Subject-Index

Acute lymphoblastic leukemia, 54
Antigen presentation, 132
Antinuclear antibodies, 90
Apoptosis, 2
Artemis, 146
Biomarker, 54
Cancer, 54
CD4 T cell proliferation, 169
CD73, 80
Cell death, 2
Cellular immunodeficiency, 109
Children, 54
Circular RNA, 122
Combined immune deficiency, 146
Common variable immune deficiency, 70
CVID, 70
DCLRE1C, 146
De-novo acute myeloid leukemia, 80
Diagnosis, 54
Dihydrorhodamine, 123 33
Enteropathy in CVID, 70
Environmental balance, 62
Evolution, 62
Extractable antinuclear antibodies, 90
FCRL3, 43
Flow cytometry, 33
Foot and mouth disease, 99
Gastrointestinal tract inflammation in, CVID 70
H1N1-PR8 influenza A virus, 22
Haemophilus influenzae, 169
Hardy-Weinberg equilibrium, 177
HLA 177,
IFN-ɣ levels, 22
IgM/IgG, 22
IL-1β and IL-6, 158
Immune checkpoints, 122
Immune response, 99
Immune system, 62
Immunogenicity, 132
Infections, 109
Inflammation, 158
Leaky severe combined immunodeficiency, 146
Linkage disequilibrium, 177
Lupus nephritis, 43
Major histocompatibility complex, 132
Maternal supplementation, 158
Mice of different genetic backgrounds, 22
Microbiota, 62
Microorganisms, 62
Molecular dynamics, 132
Necroptosis, 2
Neutrophil, 33
Next-generation sequencing, 177
Oil emulsion adjuvant, 99
PANoptosis, 2
Population genetics, 177
Programmed cell death, 1 122
Protein dynamics, 132
Protein energy networks, 132
Protein stability, 132
Pyroptosis, 2
rs11264799, 43
rs7528684, 43
sHLA-G, 54
SLE, 43
Structural bioinformatics, 132
Symbiosis, 62
Systemic autoimmune rheumatic diseases, 90
Th1 and Th2 cytokines, 169
Thymic hypoplasia, 109
Treatment outcome, 80
Typing resolution, 177
Vaccine, 99
Validation study, 33
Vitamin D₃, 158